PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Current Deferred Revenue: Rp4,540 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SIDO PT Industri Jamu dan Farmasi Sido Muncul Tbk ISX:SIDO
74 GF Score
Price Rp348.00
GF Value Rp558.39
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Industri Jamu dan Farmasi Sido Muncul Tbk Current Deferred Revenue?

PT Industri Jamu dan Farmasi Sido Muncul Tbk ISX:SIDO -1.14% 74 Current Deferred Revenue is Rp4,540 Mil as of Jun. 2026. GuruFocus rates ISX:SIDO with a GF Score™ of 74/100 and a GF Value™ of Rp558.39 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

PT Industri Jamu dan Farmasi Sido Muncul Tbk's current deferred revenue for the quarter that ended in Jun. 2026 was Rp4,540 Mil.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Current Deferred Revenue Related Terms

PT Industri Jamu dan Farmasi Sido Muncul Tbk Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for PT Industri Jamu dan Farmasi Sido Muncul Tbk's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Current Deferred Revenue Chart

PT Industri Jamu dan Farmasi Sido Muncul Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,107.00 2,815.00 17,536.00 1,944.00 1,591.00

PT Industri Jamu dan Farmasi Sido Muncul Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,389.00 2,402.00 1,591.00 1,591.00 4,540.00
ISX:SIDO
74GF Score
PT Industri Jamu dan Farmasi Sido Muncul Tbk ISX:SIDO
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of Rp4,540 Mil mean?
PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) has a Current Deferred Revenue of Rp4,540 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk's Current Deferred Revenue too high?
PT Industri Jamu dan Farmasi Sido Muncul Tbk's current Current Deferred Revenue is Rp4,540 Mil. Overall, PT Industri Jamu dan Farmasi Sido Muncul Tbk has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Industri Jamu dan Farmasi Sido Muncul Tbk's Current Deferred Revenue compare to KHC and GIS?
PT Industri Jamu dan Farmasi Sido Muncul Tbk's Current Deferred Revenue of Rp4,540 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Consumer Packaged Goods company?
A good Current Deferred Revenue depends on the Consumer Packaged Goods industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors. PT Industri Jamu dan Farmasi Sido Muncul Tbk's current Current Deferred Revenue is Rp4,540 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp558.39, compared to a current price of Rp348.00 — trading 37.7% below its estimated fair value. The current Current Deferred Revenue is Rp4,540 Mil. PT Industri Jamu dan Farmasi Sido Muncul Tbk's overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO), the current Current Deferred Revenue is Rp4,540 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Overvalued in 2026?

Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk stock appears to be undervalued. The current stock price of Rp348.00 is trading 37.7% below its estimated GF Value™ of Rp558.39. GuruFocus considers PT Industri Jamu dan Farmasi Sido Muncul Tbk to be Significantly Undervalued.

Key valuation signals for ISX:SIDO:

  • Current Deferred Revenue: Rp4,540 Mil
  • GF Value™: Rp558.39 vs. price of Rp348.00 (37.7% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the ISX:SIDO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Business Description

Address Jalan Gajahmada No. 123, 1st Floor, Tentrem Hotel Building, Office Sido Muncul, Lantai 1, Pekunden Subdistrict, Semarang, IDN, 50134
PT Industri Jamu dan Farmasi Sido Muncul Tbk is focused on the herbal medicine and herbal products industry, with its products categorized into three distinct segments: Herbal Medicine and Supplements, Food and Beverages, and Pharmaceuticals. Its flagship herbal products include Tolak Angin, available in variants such as Tolak Angin Cair, Tolak Angin Cair Anak, Tolak Angin Sugar Free, Tolak Angin Batuk, and Tolak Angin Flu. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionery products. The Pharmacy segment sells pharmaceutical products, including Anacetine Syrup, Inflasone, Berlosid, Licokalk, and Licodexon. The majority of revenue is derived from the Herbal Medicine & Supplement segment.
74GF Score

Get the complete analysis for ISX:SIDO

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp348.00
Price
Rp558.39
GF Value